<!-- Promoted from collab/reviewer-team-glm-pty-correction-r10.gemini-3.1-pro-high.stdout.log.
     Conversation e671c7ca-f04c-4750-95ab-1178f25ba4bc (resumed). -->

Completed-GMT: 2026-09-04 12:40:00 GMT
Completed-Local: 2026-09-04 19:40:00 Asia/Ho_Chi_Minh
Coding-Agent: agy
Session-ID: e671c7ca-f04c-4750-95ab-1178f25ba4bc

1. **Resolution of r9 Medium**: The finding is correctly resolved. By removing the `script` wrapper entirely from `muse`, you eliminated the root cause of the I/O brittleness that necessitated the stdin warning in the first place. Deductively applying the I/O characteristics of `glm` and `deepseek` to `muse` is completely sound because they share the exact same underlying binary (Claude Code). The CLI's interaction with the OS (PTY allocation, stdin handling) is governed by the binary, not the remote model API. Paying metered tokens to probe `muse` for an I/O test would have been redundant.
2. **Fidelity of New Paragraph**: The new introductory paragraph is highly accurate and adheres strictly to evidence reporting rules. It explicitly states that the 2026-09-04 verification was performed against `glm` and correctly cites the existing `deepseek` recipe as corroborating evidence. It draws a clear, logical conclusion about the entire CLI family without ever falsely claiming that `muse` itself was tested.
3. **Structure**: Centralizing the rationale is the correct architectural choice. A shared explanation of the underlying binary's properties provides a much stronger defense against a future maintainer cargo-culting the `script` wrapper back into the file than fragmented, per-recipe comments would.
4. **Consistency**: The file is now internally consistent. The contradiction where `deepseek` was prescribed a closed stdin while `glm/muse` were forbidden from it has been completely resolved.

| Severity | File:Line | Evidence | Correction |
| :--- | :--- | :--- | :--- |
| None | N/A | No defects found. The r9 Medium finding was rigorously resolved under the corrected premise, adhering to both the team's evidence and cost constraints. | N/A |

SIGN-OFF: GRANTED

